Next Generation Sequencing for HIV-1 Drug Resistance Testing—A Special Issue Walkthrough
Author:
Open Access
Abstract
Drug resistance remains a global challenge in the fight against the HIV pandemicKeywords
Funding Information
- National Institutes of Health (R01AI147333, R01AI136058, R01AI120792, K24AI134359 and P30AI042853)
This publication has 24 references indexed in Scilit:
- Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance SurveillanceThe Journal of Infectious Diseases, 2017
- Japanese External Quality Assessment Program to Standardize HIV-1 Drug-Resistance Testing (JEQS2010 Program) Using In Vitro Transcribed RNA as Reference MaterialAIDS Research and Human Retroviruses, 2015
- Sequence Quality Analysis Tool for HIV Type 1 Protease and Reverse TranscriptaseAIDS Research and Human Retroviruses, 2012
- Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis ToolJournal of Clinical Microbiology, 2012
- Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Clinical Infectious Diseases, 2012
- TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesJournal of Virological Methods, 2009
- HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency ProgrammeJournal of Clinical Virology, 2008
- Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistanceGenome Research, 2007
- Emerging technologies in DNA sequencingGenome Research, 2005
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977